Improving the Diagnosis and Treatment of Castleman Disease: Expert Insights

Improving the Diagnosis and Treatment of Castleman Disease: Expert Insights is organized by Paradigm Medical Communications, LLC.

Release Date: February 9, 2022 
Expiration Date: February 9, 2023

Statement of Need:
CD is a rare group of heterogeneous lymphoproliferative disorders, many of which have unknown underlying etiologies. Therefore, hematology/oncology clinicians frequently find the diagnosis and treatment of the disease to be particularly challenging, potentially resulting in delayed diagnosis or misdiagnosis, and/or inappropriate treatment selection. Guidelines for both the diagnosis and treatment of CD are now available, which can guide clinicians through the appropriate steps to improve the care of patients with CD. This program will review key factors for the diagnosis of CD subtypes and will use real-world cases to illustrate the optimal first- and second-line treatment for idiopathic multicentric CD.

Learning Objectives:
Upon completion of this activity, participants should be able to:
• Identify patients with CD
• Determine evidence-based treatment for CD in alignment with current guidelines.